미국의 미용의학 시장 규모, 점유율, 동향 분석 보고서 : 시술별, 연령층별, 용도별, 대도시권별 및 부문별 예측(2026-2033년)

U.S. Aesthetic Medicine Market Summary

The U.S. aesthetic medicine market size was valued at USD 18.8 billion in 2025 and is projected to grow from USD 19.9 billion in 2026 to USD 32.0 billion by 2033, at a CAGR of 7.0% from 2026 to 2033. The market is primarily driven by the increasing preference for minimally invasive cosmetic procedures that offer shorter recovery times, lower procedural risks, and natural-looking outcomes. Growing consumer awareness, increasing disposable income, and the rising acceptance of aesthetic treatments among younger adults and men are contributing to higher demand for injectables, skin rejuvenation procedures, and body contouring treatments.

Healthcare providers are also expanding their portfolios with advanced injectable products and energy-based technologies to address the growing patient base. For instance, in July 2024, Merz Aesthetics received U.S. FDA approval for XEOMIN to temporarily improve the appearance of moderate-to-severe platysma bands in adults, expanding its facial aesthetics portfolio in the U.S.

Market Concentration & Characteristics

The chart below illustrates the relationship among industry concentration, industry characteristics, and industry participants in the market. The market is highly fragmented, with numerous medical spas, dermatology clinics, and plastic surgery practices offering diverse services. It is characterized by a high degree of innovation, moderate merger and acquisition activity, strong regulatory oversight, and continuous expansion driven by increasing demand for minimally invasive aesthetic procedures and advanced treatment technologies.

The industry is experiencing a high degree of innovation, driven by continuous advancements in minimally invasive procedures, regenerative aesthetics, artificial intelligence, and energy-based treatment technologies. Service providers are increasingly adopting AI-powered skin analysis, personalized treatment planning, and next-generation laser and radiofrequency platforms to improve patient outcomes. For instance, in July 2026, SkinSpirit expanded its regenerative aesthetics portfolio by launching a PDRN (Salmon DNA) Microneedling Catalyst Serum Treatment to address the growing demand for advanced skin rejuvenation therapies.

The level of mergers and acquisitions is moderate to high, supported by rising private equity investment and consolidation among medical spa and aesthetic clinic networks. Leading providers continue to expand their geographic footprint and service offerings through acquisitions and strategic partnerships, strengthening their presence in the highly competitive U.S. market.In September 2025, Spa Medicca completed the strategic acquisition of Skin Science Aesthetics, with Viper Partners serving as the exclusive financial advisor. The transaction expanded Spa Medicca's presence in Florida, strengthened its aesthetic service portfolio, and supported its long-term regional growth strategy through an established clinical platform.

The industry operates under a high level of regulatory oversight, with aesthetic medical devices, dermal fillers, laser systems, and botulinum toxin products regulated by the U.S. Food and Drug Administration. In addition, physicians and aesthetic practitioners must comply with state-specific licensing requirements and clinical practice standards to ensure patient safety and treatment quality.

The U.S. aesthetic medicine market continues to expand, driven by the introduction of advanced treatment technologies and the rapid growth of medical spas and specialty aesthetic clinics. The expansion of multi-location medical spa chains, coupled with rising private equity investments and growing adoption of AI-enabled consultation platforms, is further enhancing access to aesthetic services across the country. These developments are enabling providers to improve treatment outcomes, enhance patient experience, and strengthen their competitive position, supporting sustained market growth.

U.S. Aesthetic Medicine Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033 For this study, Grand View Research has segmented the U.S. aesthetic medicine market report based on procedure, age group, end use, and metropolitan cities:

• Procedure Outlook (Revenue, USD Billion, 2021 - 2033)
• Invasive Procedures
  • Breast augmentation
  • Liposuction
  • Nose reshaping
  • Eyelid Surgery
  • Tummy tuck
  • Others
• Non-invasive Procedures
  • Botox injections
  • Soft tissue fillers
  • Chemical peel
  • Laser hair removal
  • Microdermabrasion
  • Others
• Age Group Outlook (Revenue, USD Billion, 2021 - 2033)
• 19 and under
• 20-29
• 30-39
• 40-54
• 55-69
• 70+
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Clinics & Aesthetic Centers
• Medspas
• Metropolitan Cities Outlook (Revenue, USD Billion, 2021 - 2033)
• New York
• Los Angeles
• Chicago
• Dallas
• Houston
• Washington
• Miami
• Philadelphia
• Atlanta
• Phoenix
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Commodity Flow Analysis
• 1.6. Data Validation & Publishing
• 1.7. List of Secondary Sources
• 1.8. Research Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. U.S. Aesthetic Medicine Market- Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Adoption of Aesthetic Procedures Among Men
    • 3.2.1.2. Increased Social Media Influence Shaping Beauty Standards
    • 3.2.1.3. Growing Geriatric Population Driving Demand for Anti-Aging Aesthetic Treatments
    • 3.2.1.4. Rising Demand for Minimally Invasive Procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulatory framework
    • 3.2.2.2. Complications related to liposuction and postoperative complications related to nose reshaping
• 3.3. Patient Perspective Analysis
  • 3.3.1. Consumer behavior analysis
  • 3.3.2. Market influencer analysis
• 3.4. Number of Plastic Surgeons in 2025
• 3.5. Major Deals & Strategic Alliances Analysis
• 3.6. Business Environmental Tools Analysis: U.S. Aesthetic Medicine Market
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTLE Analysis

Chapter 4. U.S. Aesthetic Medicine Market: Procedure Estimates & Trend Analysis

• 4.1. U.S. Aesthetic Medicine Market, By Procedure: Key Takeaways
• 4.2. U.S. Aesthetic Medicine Market: Procedure Movement & Market Share Analysis, 2025 & 2033
  • 4.2.1. Invasive Procedures
    • 4.2.1.1. Invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.1.2. Breast Augmentation
      • 4.2.1.2.1. Breast Augmentation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.1.3. Liposuction
      • 4.2.1.3.1. Liposuction Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.1.4. Nose Reshaping
      • 4.2.1.4.1. Nose Reshaping Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.1.5. Eyelid Surgery
      • 4.2.1.5.1. Eyelid Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.1.6. Tummy Tuck
      • 4.2.1.6.1. Tummy Tuck Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.1.7. Others
      • 4.2.1.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.2.2. Non-invasive Procedures
    • 4.2.2.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.2.2. Botox Injections
      • 4.2.2.2.1. Botox Injections Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.2.3. Soft Tissue Fillers
      • 4.2.2.3.1. Soft Tissue Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.2.4. Chemical Peel
      • 4.2.2.4.1. Chemical Peel Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.2.5. Laser Hair Removal
      • 4.2.2.5.1. Laser Hair Removal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.2.6. Microdermabrasion
      • 4.2.2.6.1. Microdermabrasion Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.2.2.7. Others
      • 4.2.2.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Aesthetic Medicine Market: Age Group Estimates & Trend Analysis

• 5.1. U.S. Aesthetic Medicine Market, By Age Group: Key Takeaways
• 5.2. U.S. Aesthetic Medicine Market: Age Group Movement & Market Share Analysis, 2025 & 2033
  • 5.2.1. 19 and under
    • 5.2.1.1. 19 and under Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.2.2. 20-29
    • 5.2.2.1. 20-29 Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.2.3. 30-39
    • 5.2.3.1. 30-39 Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.2.4. 40-54
    • 5.2.4.1. 40-54 Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.2.5. 55-69
    • 5.2.5.1. 55-69 Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.2.6. 70+
    • 5.2.6.1. 70+ Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Aesthetic Medicine Market: End Use Estimates & Trend Analysis

• 6.1. U.S. Aesthetic Medicine Market, By End-use: Key Takeaways
• 6.2. U.S. Aesthetic Medicine Market: End-use Movement & Market Share Analysis, 2025 & 2033
  • 6.2.1. Hospitals
    • 6.2.1.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.2.2. Clinics & Aesthetic Centers
    • 6.2.2.1. Clinics & Aesthetic Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.2.3. Medspas
    • 6.2.3.1. Medspas Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. U.S. Aesthetic Medicine Market: Metropolitan Cities Estimates & Trend Analysis

• 7.1. Metropolitan Cities Market Share, 2025 & 2033
• 7.2. Segment Dashboard
• 7.3. U.S. Aesthetic Medicine Market by Metropolitan Cities Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
  • 7.4.1. New York
    • 7.4.1.1. New York Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.2. Los Angeles
    • 7.4.2.1. Los Angeles Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.3. Chicago
    • 7.4.3.1. Chicago Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.4. Dallas
    • 7.4.4.1. Dallas Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.5. Houston
    • 7.4.5.1. Houston Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.6. Washington
    • 7.4.6.1. Washington Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.7. Miami
    • 7.4.7.1. Miami Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.8. Philadelphia
    • 7.4.8.1. Philadelphia Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.9. Atlanta
    • 7.4.9.1. Atlanta Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.10. Phoenix
    • 7.4.10.1. Phoenix Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.11. Others
    • 7.4.11.1. Others Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key Company Market Position Analysis, 2025
• 8.4. Company Profile
  • 8.4.1. Ideal Image Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. LaserAway
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Milan Laser Hair Removal
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. SkinSpirit
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Sono Bello
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. AirSculpt Technologies
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. OrangeTwist
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Mia Aesthetics
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. SEV Laser
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Service benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Chapter Aesthetic Studio
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Service benchmarking
    • 8.4.10.4. Strategic initiatives